MRI screening in a clinic population with a family history of breast cancer

Annals of Surgical Oncology

Volumn 15, Issue 2, 2008, Pages 452-461

  Yu, Jeanne ^a   Park, Anna ^a   Morris, Elizabeth ^a   Liberman, Laura ^a   Borgen, Patrick I ^a,b   King, Tari A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Maimonides Cancer Center   (United States)

Author keywords

Breast cancer screening; Familial breast cancer; Family history; Magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; RETROSPECTIVE STUDY; BREAST TUMOR; FEMALE; GENETICS; HEALTH SURVEY; IMAGE PROCESSING; INCIDENCE; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MUTATION; PAGET NIPPLE DISEASE; PATHOLOGY; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE; UNITED STATES;

ADULT; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FALSE NEGATIVE REACTIONS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INCIDENCE; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MIDDLE AGED; MUTATION; NEW YORK CITY; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 40649094780     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9622-2     Document Type: Article

References (27)

1. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin 2006; 56(3):168-83.
2. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81(24):1879-86.
3. Satagopan JM, Offit K, Foulkes W, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2001; 10(5):467-73.
4. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312(3):146-51.
5. Page DL, Kidd TE Jr., Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22(12):1232-9.
6. Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 1997; 79(6):1203-10.
7. Lacroix M, Leclercq G. The "portrait" of hereditary breast cancer. Breast Cancer Res Treat 2005; 89(3):297-304.
8. Chen S, Iversen ES, Friebel T, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 2006; 24(6):863-71.
9. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90(18):1371-88.
10. Schrag D, Kuntz KM, Garber JE, Weeks JC. Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations. JAMA 2000; 283(23):3070-2.
11. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003; 181(3):619-26.
12. Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: Comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr 2006; (36):112-21.
13. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57(2):75-89.
14. Port ER, Park A, Borgen PI, Morris E, Montgomery LL. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 2007; 14:1051-7.
15. Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002; 178(5):1211-20.
16. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: Features and positive predictive value. AJR Am J Roentgenol 2002; 179(1):171-8.
17. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137(5 Part 1):347-60.
18. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23:8469-76.
19. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002; 21:115-24.
20. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000; 63:53-60.
21. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103:1898-05.
22. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351:427-37.
23. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292:1317-25.
24. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 2005; 365:1769-78.
25. Lehman CD. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006; 24:964-70.
26. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997; 89(3):227-38.
27. National Cancer Institute Breast Cancer Risk Assessment Tool (2007) Available: http://www.cancer.gov/bcrisktool (accessed July 27 2007).